Vasogen's immune modulation therapy (IMT) improves postischemic foot skin blood flow and transcutaneous pO(2) recovery rates in patients with advanced peripheral arterial occlusive disease.

Lars Edvinsson, M L Edvinsson, G Angus Deveber

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)141-147
JournalInternational Angiology
Volume22
Issue number2
Publication statusPublished - 2003

Subject classification (UKÄ)

  • Cardiac and Cardiovascular Systems

Cite this